Nexelis

371 – Women’s sexual health: desire, arousal, and orgasms, navigating perimenopause, and more

Peter Attia MD

A newer medication containing drospirenone and estetrol (E4), a natural estrogen with a longer half-life, resulting in less breakthrough bleeding and no activation of the angiotensinogen pathway.